
    
      The duration of the study per patient will be approximately 2 years. Each patient will be
      treated until radiographic disease progression, unacceptable toxicity, or patient's refusal
      of further study treatment, and each patient will be followed after completion of study
      treatment until death, study cutoff date, or withdrawal of patient consent.
    
  